The American Academy of Ophthalmology's winning pitch challenge is a privately sponsored competition with the goal of accelerating innovation in eyecare. AesculaTech was recently selected as a finalist after ...
After a highly competitive review process, AesculaTech's Humidifeye has received SBIR funding from National Eye Institute (NEI) at the U.S. National Institutes of Health (NIH). The total value of ...
Humidifeye, AesculaTech's groundbreaking treatment for Dry Eye, treated 22 patients in a 3-month OUS first in Human study. Study endpoints included safety, signs, symptoms, and patient-reported metrics for satisfaction. ...
The AesculaTech team met with Optometry thought leaders at Vision Expo 2022 - and we didn't come empty handed. We put our Humidifeye device in front of some of ...
AesculaTech was one of a few selected companies showcased at Plug and Play's 2022 LA Tech Week. Roby Menefee, Head of Material Development, shared the company vision of smart ...
This month, the AesculaTech team met with CDRH at FDA to discuss the Humidifeye device. The FDA confirmed that Humidifeye is a 510(k) device and a predicate was established. ...
